Quantcast

Latest APL Stories

2012-11-20 13:40:37

May provide treatment option for those with harder-to-treat memory problems, skin ulcers and kidney disease Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal...

2012-11-12 11:58:24

New research suggests that statins, traditionally used for cholesterol lowering, could be used in the management of individuals who are at risk for developing clotting because they have autoimmune antiphospholipid antibodies (aPL). The research will be presented in two presentations at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP). The meeting will be held Nov. 9-14, in Washington D.C. "What we have shown is that...

NASA Renames Radiation Belt Mission
2012-11-10 09:36:40

April Flowers for redOrbit.com — Your Universe Online NASA announced the renaming of a recently launched mission to study the radiation belts to the Van Allen Probes in honor of the late James Van Allen, head of the physics department at the University of Iowa. Van Allen discovered the radiation belts encircling Earth in 1958. NASA announced the new name, previously the Radiation Belt Storm Probes (RBSP), at a ceremony at the Johns Hopkins University Applied Physics Laboratory...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.